OPIA RZECZKA GENERALGO JULIE KOKOTT

Summaries of Allegations Matters that will be proceeding before the Discipline Committee, and the hearing dates (if known). Downloaded December 10, 2012 Member Summary of Allegations

Bennett, Andrew

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Bennett committed professional misconduct in that he

• failed to cancel unused and/or re-‐used doses; • billed patient G.H. daily for Plavix 75mg from December

21, 2007 to April 27, 2008; • billed patient C.B. daily for medications from March 24,

2008 to July 31, 2008; • billed patient V.C. weekly for medications from February

11, 2008 to July 25, 2008, and again from August 29, 2008 to October 10, 2008;

• charged an individual dispensing fee for each of multiple doses of methadone dispensed to patients as carries in the absence of a methadone capitation agreement;

• charged an individual dispensing fee for each of 2 prescriptions of Gabapentin 300mg dispensed concurrently to G.B. from August 24, 2007 to November 20, 2007, pursuant to the transfer of only 1 prescription to the pharmacy;

• dispensed methadone doses to patients as carries without authorization;

• dispensed Rx# 1008996, 1008999 and 1009001 without authorization;

• failed to maintain records as required;

• reduced the quantity of methadone dispensed without authorization;

• dispensed drugs in weekly compliance pill packs in less than the full amount prescribed for patients without informed authorizations in writing from those patients;

• recorded 2 prescriptions of Gabapentin 300mg dispensed concurrently to G.B. from August 24, 2007 to November 20, 2007, pursuant to the transfer of only 1 prescription to the pharmacy;

In particular, it is alleged that he:

• failed to maintain the standards of practice of the profession;

• failed to keep records as required respecting the member’s patients;

• falsified a record relating to the member’s practice; • charged a fee that was excessive in relation to the service

provided; • contravened the Pharmacy Act, the Drug and Pharmacies

Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 156 of theDrug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, as amended;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 9 of the Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23; section 5 of O.Reg. 936 under the Drug Interchangeability and Dispensing Fee Act; sections 5, 6(2) and 15(a) and (b) of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10; subsections 18(7), 18(8), 18(9) and 18(10) of Ontario Regulation 201/96 under the Ontario Drug Benefit Act; and section 38 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs

and Substances Act, S.C. 1996, c. 19, as amended; • engaged in conduct or performed an act relevant to the

practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Date: TBA As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Bennett committed professional misconduct in that he

• charged an individual dispensing fee for each of multiple doses of methadone dispensed to patients as carries in the absence of a methadone capitation agreement from October 14, 2009 to March 5, 2011

In particular, it is alleged that he


• submitted an account or charge for services that he knew was false or misleading;

• charged a fee that is excessive in relation to the service provided;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 20 of Ontario Regulation 201/96 under the Ontario Drug Benefit Act;

• engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or

unprofessional

Hearing Date: TBA

Member Summary of Allegations

Fahmy, Armia As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Fahmy committed professional misconduct in that he

• on or about October 14, 2011, purported to authorize the refill of a prescription for patient Mr. J.B. without complying with all of the conditions set out in s. 42 of Ontario Regulation 58/11 made under the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, thereby contravening that section of that regulation;

• on or about December 21, 2011, entered a new prescription for patient D.B., when this was in fact a refill of a prescription dated November 16, 2011, without properly documenting this fact;

• on or about November 6, 2011, dispensed drugs to patient R.S. pursuant to a verbal authorization from a prescriber, without complying with all of the conditions set out in s. 40 of Ontario Regulation 58/11 made under the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, thereby contravening that section of that regulation;

• dispensed drugs pursuant to a prescription without ensuring the information prescribed by s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, was recorded on the prescription;

• failed to take all reasonable steps necessary to protect narcotics and controlled substances at the pharmacy against loss or theft and, in particular, failed to maintain accurate inventories and other records of narcotics and controlled substances purchased by and dispensed at the pharmacy and/or failed to report loss or theft of narcotics and controlled substances and/or to otherwise account for

inventory discrepancies, for the period from April 1, 2011 to May 1, 2012;

• failed to obtain confirmation of a patient’s prior dose of methadone before dispensing methadone to that patient, and/or failed to keep a record of that confirmation;

• created a misleading and/or inaccurate dispensing record by backdating dispensing records to a date different than the date on which the records were created, without appropriately documenting that fact;

• dispensed drugs pursuant to a prescription without ensuring the information prescribed by s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, was recorded on the container on which the drugs were dispensed;

• inaccurately recorded the identity of the prescriber in patient and pharmacy records;

• dispensed drugs pursuant to a prescription while inaccurately recording the identity of the prescriber on prescription hardcopies, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• created a misleading and/or inaccurate dispensing record by dispensing drugs pursuant to prescription hardcopies containing the notation “reprint” and/or “modified reprint,” without documenting that there was no original hardcopy and/or without documenting the changes from the original hardcopy;

• dispensed narcotics pursuant to prescriptions that were not signed by the prescribers, contrary to s. 40 of Ontario Regulation 58/11 made under the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, and s. 155 of that Act, and to s. 31 of the Narcotic Control Regulations, C.R.C. c. 1041, made under the Controlled Drugs and Substances Act, S.C. 1996, c. 19;

• dispensed drugs pursuant to a prescription while inaccurately and/or unclearly recording directions for use compared with those intended by the prescriber, contrary to s. 156 of the Drug and Pharmacies Regulation Act,

R.S.O. 1990, c. H-‐4; • dispensed different drugs than those authorized by the

prescriber, contrary to s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, and/or to s. C.01.041 of the Food and Drug Regulations, C.R.C., c. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-‐27, and/or to s. 31 of the Narcotic Control Regulations, C.R.C. c. 1041, made under the Controlled Drugs and Substances Act, S.C. 1996, c. 19;

• dispensed drugs pursuant to a prescription as dispensing pharmacist without recording his signature on the prescription, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed drugs pursuant to a prescription while incorrectly recording the quantity of drug authorized by the prescriber, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed drugs pursuant to a prescription while incorrectly recording the quantity and/or strength of the drug dispensed, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed drugs pursuant to a prescription while incorrectly recording the date on which the drug was dispensed to the patient, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed narcotics without authorization from a prescriber and/or on a date not authorized by the prescriber, contrary to s. 155 of theDrug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, and s. 31 of the Narcotic Control Regulations, C.R.C. c. 1041, made under theControlled Drugs and Substances Act, S.C. 1996, c. 19;

• dispensed narcotics to patients on days not authorized by a prescriber, contrary to s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, and s. 31 of the Narcotic Control Regulations, C.R.C. c. 1041, made under the Controlled Drugs and Substances Act, S.C. 1996,

c. 19; • dispensed drugs pursuant to a prescription in a quantity

less than the entire quantity authorized by the prescriber, contrary to s. 9 of theDrug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23;

and/or

• dispensed a narcotic to patient D.H. pursuant to a prescription after the quantity of the narcotic specified in the prescription had already been dispensed, contrary to s. 37 of the Narcotic Control Regulations, C.R.C., c. 1041, made under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, on or about February 7, 2012.


• failed to maintain a standard of practice of the profession; • contravened the Act, the Drug and Pharmacies Regulation

Act, theRegulated Health Professions Act, 1991, or the regulations under those Acts;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs;

• engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Date: TBA


Guirguis, Sameh

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Guirguis committed professional misconduct in that he

• dispensed drugs pursuant to a prescription without ensuring the information prescribed by s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, was recorded on the prescription;

• failed to obtain confirmation of a patient’s prior dose of methadone before dispensing methadone to that patient, and/or failed to keep a record of that confirmation;

• created a misleading and/or inaccurate dispensing record by backdating dispensing records to a date different than the date on which the records were created, without appropriately documenting that fact;

• dispensed drugs pursuant to a prescription without ensuring the information prescribed by s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, was recorded on the container on which the drugs were dispensed;

• dispensed drugs pursuant to a prescription while inaccurately recording the identity of the prescriber on prescription hardcopies, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• created a misleading and/or inaccurate dispensing record by dispensing drugs pursuant to prescription hardcopies containing the notation “reprint” and/or “modified reprint,” without documenting that there was no original hardcopy and/or without documenting the changes from the original hardcopy;

• dispensed drugs pursuant to a prescription while inaccurately and/or unclearly recording directions for use compared with those intended by the prescriber, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed different drugs than those authorized by the prescriber, contrary to s. 155 of the Drug and Pharmacies

Regulation Act, R.S.O. 1990, c. H-‐4, and s. G.03.002 of the Food and Drug Regulations, C.R.C., c. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-‐27;

• dispensed drugs pursuant to a prescription while incorrectly recording the quantity of drug authorized by the prescriber, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed Schedule 1 drugs in quantity greater than that authorized by the prescriber, contrary to s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, and s. G.03.002 of the Food and Drug Regulations, C.R.C., c. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-‐27;

• dispensed drugs pursuant to a prescription while incorrectly recording the quantity and/or strength of the drug dispensed, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed drugs pursuant to a prescription while incorrectly recording the date on which the drug was dispensed to the patient, contrary to s. 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• dispensed narcotics without authorization from a prescriber and/or on days not authorized by the prescriber, contrary to s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, and s. 31 of theNarcotic Control Regulations, C.R.C. c. 1041, made under theControlled Drugs and Substances Act, S.C. 1996, c. 19;

• dispensed drugs pursuant to a prescription in a quantity less than the entire quantity authorized by the prescriber, contrary to s. 9 of theDrug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23;

and/or

• refilled a prescription for a controlled drug for patient L.P. when the prescriber did not indicate the dates for or the

intervals between refills, contrary to s. G.03.006 of the Food and Drug Regulations, C.R.C., c. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-‐27, on or about November 12, 2011.



Act, theRegulated Health Professions Act, 1991, or the regulations under those Acts;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs;


Hearing Date: TBA


Ha, To As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ha committed professional misconduct in that he

• falsified pharmacy records relating to his practice in connection with claims made for drugs in 2009;

• signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for drugs in 2009;

• submitted an account or charge for services that he knew was false or misleading in connection with claims made for

drugs in 2009


• failed to maintain a standard of practice of the profession; • falsified a record relating to his practice; • signed or issued, in his professional capacity, a document

that he knew contained a false or misleading statement; • submitted an account or charge for services that he knew

was false or misleading; • contravened the Act, the Drug and Pharmacies Regulation

Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, as amended;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefits Act, R.S.O. 1990, c O.10, and sections 25 and 27 of Regulation 201/96 under the Ontario Drug Benefits Act;


Hearing Date: TBA


Haditaghi, Majid

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Haditaghi committed professional misconduct in that he

• failed to maintain records as required • improperly stored drugs

• failed to cancel unused and/or re-‐used doses • dispensed reduced quantities without written

authorization • incompletely transcribed verbal authorizations


• failed to maintain the standards of practice of the profession

• failed to keep records as required respecting his patients • contravened the Act, the Drug and Pharmacies Regulation

Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs


Hearing Date: TBA


Lai, Samuel As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Lai committed professional misconduct in that he:

• falsified pharmacy records relating to his practice in connection with claims made for drugs in 2009;

• signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for drugs in 2009;

• submitted an account or charge for services that he knew was false or misleading in connection with claims made for

drugs in 2009.


• failed to maintain a standard of practice of the profession; • falsified a record relating to his practice; • signed or issued, in his professional capacity, a document




• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefits Act, R.S.O. 1990, c O.10, and sections 25 and 27 of Regulation 201/96 under the Ontario Drug Benefits Act;


Hearing Date: January 8, 2013


Ogowa, Godwin As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ogowa committed professional misconduct in that he

• failed to complete the remedial training required by subparagraph 3(ii)(a) of the order of the Discipline

Committee of the Ontario College of Pharmacists dated June 9, 2008 (the “Order”) within the time required by the Order;

• failed to comply with the terms of an Acknowledgement and Undertaking you entered into with the Ontario College of Pharmacists dated January 26, 2011, and in particular, failing to successfully complete the Jurisprudence Examination at the sitting held on April 20, 2011, as required by that Acknowledgement and Undertaking.


• contravened a term, condition or limitation imposed on his certificate of registration;


Hearing Date: TBD


Patel, Maheshkumar

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Patel committed profession misconduct in that he

• misappropriated narcotics and/or other drugs from the pharmacy on or about 10 occasions in or about June-‐November 2011;



Act, theRegulated Health Professions Act, 1991, or the

regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Food and Drug Regulations, C.R.C., c. 870, as amended, sections C.01.041 and/or G.03.002; the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended, section 4; and/or the Narcotic Control Regulations, C.R.C. c.1041, as amended, section 31;


Hearing Date: TBA


Pham Buu, Thi As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Pham Buu committed professional misconduct in that she

• falsified pharmacy records relating to her practice in connection with claims made in 2007-‐2009;

• signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement in connection with claims made in 2007-‐2009;

• submitted an account or charge for services that she knew was false or misleading in connection with claims made in 2007-‐2009;

• failed to exercise appropriate judgment when providing patient care in connection with the dispensing of potentially duplicative medications to Patient N.T. and Patient H.N.

In particular, it is alleged that she • failed to maintain a standard of practice of the profession; • falsified a record relating to her practice; • signed or issued, in her professional capacity, a document

that she knew contained a false or misleading statement; • submitted an account or charge for services that she knew



• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefits Act, R.S.O. 1990, c O.10, and section 25 of Regulation 201/96 under the Ontario Drug Benefits Act;


Hearing Date: February 11 and 12, 2013


Phull, Amanpreet

As result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Phull committed professional misconduct in that he

• While practising as a pharmacist at Shoppers Drug Mart 1369 in Brampton, Ontario,dispensed and/or permitted to be dispensed drugs pursuant to a copy of a prescription that did not originate with the prescriber without ensuring an original prescription was provided before the drugs were dispensed and/or released, on about January 24,

2010; • falsified a prescription attributed to patient D.B.

pursuant to which he dispensed drugs on about January 24, 2010;

• falsified pharmacy records relating to a prescription attributed to patient D.B. that was not authorized by a prescriber, and pursuant to which he dispensed drugs on about January 24, 2010;

• signed or issued prescription hardcopies that he knew contained a false or misleading statement relating to a prescription attributed to patient D.B. that was not authorized by a prescriber, and pursuant to which he dispensed drugs on about January 24, 2010;

• submitted an account or charge for services that he knew was false or misleading to a third-‐party insurer relating to a prescription attributed to patient D.B. that was not authorized by a prescriber, and pursuant to which he dispensed drugs on about January 24, 2010;

• dispensed Schedule I and/or Schedule F drugs pursuant to a prescription that was not authorized by a prescriber on about January 24, 2010; and/or

While practising as a pharmacist at Mavis Pharmacy Pharmachoice in Mississauga, Ontario,

• dispensed drugs pursuant to a prescription and failed to accurately record the quantity of the drug prescribed, and/or failed to verify the quantity of the drug prescribed when required, and/or failed to accurately record the directions for use as prescribed, and/or failed to cross-‐reference the dispensing of other medication prescribed, and/or failed to document that counseling had occurred, and/or failed to sign the prescription hardcopy as dispensing pharmacist;

• falsified pharmacy records relating to a prescription attributed to patient N.H. that was not authorized

by a prescriber, and pursuant to which he dispensed a narcotic on about August 10, 2010;

• signed or issued prescription hardcopies that he knew contained a false or misleading statement relating to a prescription attributed to patient N.H. that was not authorized by a prescriber, and pursuant to which he dispensed a narcotic on about August 10, 2010;

• submitted an account or charge for services that he knew was false or misleading to a third-‐party insurer relating to a prescription attributed to patient N.H. that was not authorized by a prescriber, and pursuant to which he dispensed a narcotic on about August 10, 2010; and/or

• dispensed a narcotic without a prescription authorized by a prescriber with respect to a prescription attributed to patient N.H. on about August 10, 2010



• falsified a record relating to his practice; • signed or issued, in his professional capacity, a document



Act, theRegulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and 156 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-‐4, as amended;

• contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section

C.01.041 of the Food and Drug Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-‐27, as amended, and/or section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;


Hearing Dates: March 4, 5 and 6, 2013 As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Phull committed professional misconduct in that he

• While practising as a pharmacist at Mavis Pharmacy Pharmachoice in Mississauga, Ontario,

• falsified prescriptions attributed to patients N.H., T.P., S.A., and H.B., of various dates;

• dispensed drugs for an improper purpose relating to prescriptions attributed to patients N.H., T.P., S.A. and H.B. of various dates and pursuant to which he dispensed drugs on various dates;

• falsified pharmacy records relating to prescriptions attributed to patients N.H., T.P., S.A., and H.B. of various dates that were not authorized by a prescriber, and pursuant to which he dispensed drugs on various dates;

• signed or issued prescription hardcopies that he knew contained a false or misleading statement relating to prescriptions attributed to patients N.H., T.P., S.A., and H.B., of various dates that were not authorized by a prescriber, and pursuant to which

he dispensed drugs on various dates; • submitted an account or charge for services that he

knew was false or misleading to a third-‐party insurer relating to prescriptions attributed to patients N.H., T.P., S.A., and H.B., of various dates that were not authorized by a prescriber, and pursuant to which he dispensed drugs on various dates;

• dispensed a narcotic on various dates pursuant to prescriptions attributed to patients N.H., T.P., S.A., H.B., M.P., S.S., and J.J., of various dates that were not authorized by a prescriber;

• failed to verify the authenticity of a prescription before dispensing drugs pursuant to it, in circumstances where such verification was required, relating to prescriptions attributed to patients M.P., S.S. and J.J. of various dates that were not authorized by a prescriber, and pursuant to which he dispensed drugs on various dates



• dispensed drugs for an improper purpose; • falsified a record relating to his practice; • signed or issued, in his professional capacity, a document



Act, theRegulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-‐4, as amended;

• contravened a federal or provincial law or municipal by-‐

law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19;


Hearing Dates: March 4, 5, and 6, 2013


Samwaiel, Sherif

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Samwaiel committed professional misconduct in that he ·∙ falsified pharmacy records relating to his practice in connection with: ·∙ claims made for various drugs in 2008-‐2010 ·∙ various invoices purporting to be from Canadian Pharmaceutical Supply in 2009-‐2010 ·∙ the Statement of Accounts payable at November 30, 2010 for Mr. M.K. ·∙ signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for various drugs in 2008-‐2010; In particular, it is alleged that he ·∙ failed to maintain a standard of practice of the profession; ·∙ falsified a record relating to his practice; ·∙ signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement; ·∙ submitted an account or charge for services that he knew was false or misleading;

·∙ contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, as amended; ·∙ contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefits Act, R.S.O. 1990, c O.10, and section 25 of Regulation 201/96 under the Ontario Drug Benefits Act; ·∙ engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA


Savji, Shaffique As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Savji committed professional misconduct in that he sexually abused a patient, L.G., in or about July 2009; dispensed a narcotic, Hydromorph Contin 3mg, to a patient, L.G., in excess of the amount prescribed and in exchange for sexual favours, in or about July 2009; and/or failed to take all reasonable steps necessary to protect narcotics at the pharmacy against loss or theft and, in particular, failed to maintain accurate inventories and other records of narcotics purchased by and dispensed at the pharmacy and/or failed to report loss or theft of narcotics, in or about 2009-‐2010. In particular, it is alleged that he: ·∙ sexually abused a patient with inappropriate comment and/or physical contact, at the pharmacy and/or the patient’s home, in or about July 2009; ·∙ failed to maintain the standards of practice of the profession;

·∙ dispensed or sold drugs for an improper purpose; ·∙ contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-‐4, as amended, , and/or sections 63-‐64 of Regulation 551 under that Act, as amended; ·∙ contravened a federal or provincial law or municipal by-‐law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section c.01.041(1.1) of the Food and Drug Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-‐27, as amended, and/or sections 42 and/or 43 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended; ·∙ knowingly permitted the premises in which a pharmacy was located to be used for unlawful purposes; ·∙ engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: February 19, 20, 21, and 22, 2013

Here is how the Ontario College of Pharmacists Works:

http://www.ocpinfo.com/client/ocp/OCPHome.nsf/web/About+OCP

Documents

OPIA RZECZKA GENERALGO JULIE KOKOTT